🚀

NTRA Natera Inc

Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Life Sciences Tools & Services > Life Sciences Tools & Services  | NASDAQ, LargeCap, BiotechHealthcare |  Last Price: 208.04 | 2026-02-27 | Atrp: 4.29

Sat 21 Feb 2026 to Fri 27 Feb 2026: Score 45

MetricPreviousNewChangeInterpretation
✅EPS Estimate Next Year-1.9864-0.0002▲ 99.99%Bullish. Higher is better. Substantial raised expectations for further out
Expected earnings per share next year
✅Operating Margin TTM-16.48%-3.42%▲ 79.25%Bullish. Higher is better. Operating margin TTM decline slowing; potential stabilization.
Percentage of revenue left after operating expenses
✅Book Value9.10512.378▲ 35.95%Bullish. Higher is better. Significant increase; stock now trades closer to book value
Net asset value of the company per share
✅Profit Margin-14.61%-9.03%▲ 38.19%Bullish. Higher is better. Profit margin decline slowing; potential stabilization.
Percentage of revenue that turns into profit
✅Return On Equity TTM-29.02%-14.32%▲ 50.65%Bullish. Higher is better. Return on equity TTM decline slowing; potential stabilization.
Efficiency in generating profits from shareholders' equity
✅Return On Assets TTM-12.89%-9.54%▲ 25.99%Bullish. Higher is better. Return on assets TTM decline slowing; potential stabilization.
Efficiency in generating profits from total assets
✅EBITDA$-318.19M$-270.73M▲ 14.92%Bullish. Higher is better. Increase in earnings before interest, taxes, depreciation, and amortization; indicates stronger operational cash flow
Earnings before interest, taxes, depreciation, and amortization
✅EPS Estimate Current Year-2.419-1.9694▲ 18.59%Bullish. Higher is better. Moderate increase; improved outlook for current year earnings
Expected earnings per share this year
✅Quarterly Revenue Growth YOY351%401%▲ 14.7%Bullish. Higher is better. Quarterly revenue growth YOY growth accelerating.
Year-over-year growth in quarterly revenue
✅Gross Profit TTM$1347.39M$1493.18M▲ 10.82%Bullish. Higher is better. Moderate increase, but margins may be improving
Revenue minus cost of goods sold over the trailing twelve months
✅Revenue TTM$2116.68M$2306.11M▲ 8.95%Bullish. Higher is better. Slight top-line expansion
Total revenue over the trailing twelve months
✅Revenue Per Share TTM15.6816.867▲ 7.57%Bullish. Higher is better. Slight improvement
Revenue generated per outstanding share over the trailing twelve months
✅Price Sales TTM13.974713.0674▼ -6.49%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Enterprise Value$27.91B$29.29B▲ 4.93%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash
✅Short Ratio3.152.91▼ -7.62%Bullish. Lower is better. Slight improvement
✅Short Percent2.55%2.45%▼ -3.92%Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
❌Price Book MRQ22.966724.0658▲ 4.79%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Enterprise Value/Revenue13.188113.8383▲ 4.93%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue

Sat 07 Feb 2026 to Sat 14 Feb 2026: Score -2

MetricPreviousNewChangeInterpretation
❌Price Sales TTM13.376513.5867▲ 1.57%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Price Book MRQ22.611422.9667▲ 1.57%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Enterprise Value/Revenue12.977913.1881▲ 1.62%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Short Ratio3.043.15▲ 3.62%Bearish. Lower is better. Slight decline
✅Enterprise Value$27.47B$27.91B▲ 1.62%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash
✅Short Percent2.59%2.55%▼ -1.54%Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short

Fri 30 Jan 2026 to Sat 07 Feb 2026: Score 6

MetricPreviousNewChangeInterpretation
✅Price Sales TTM15.186313.3765▼ -11.92%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Price Book MRQ25.778622.6114▼ -12.29%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Enterprise Value/Revenue14.851612.9779▼ -12.62%Bullish. Lower is better. Moderate improvement
Enterprise value divided by revenue
❌Enterprise Value$31.44B$27.47B▼ -12.62%Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Fri 23 Jan 2026 to Fri 30 Jan 2026: Score 12

MetricPreviousNewChangeInterpretation
✅Short Ratio4.23.04▼ -27.62%Bullish. Lower is better. Significant improvement
✅Short Percent3.55%2.59%▼ -27.04%Bullish. Lower is better. Significant decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
✅Price Sales TTM16.003215.1863▼ -5.1%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Price Book MRQ27.03725.7786▼ -4.65%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Enterprise Value/Revenue15.59614.8516▼ -4.77%Bullish. Lower is better. Slight improvement
Enterprise value divided by revenue
❌Enterprise Value$33.01B$31.44B▼ -4.77%Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Wed 14 Jan 2026 to Fri 23 Jan 2026: Score -3

MetricPreviousNewChangeInterpretation
❌EPS Estimate Next Year-1.9597-1.9857▼ -1.33%Bearish. Higher is better. Slight lowered expectations for further out
Expected earnings per share next year
❌Price Sales TTM15.672516.0032▲ 2.11%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Price Book MRQ26.492527.037▲ 2.06%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Enterprise Value/Revenue15.273915.596▲ 2.11%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
✅Enterprise Value$32.33B$33.01B▲ 2.11%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Tue 06 Jan 2026 to Wed 14 Jan 2026: Score -6

MetricPreviousNewChangeInterpretation
❌Short Ratio2.174.2▲ 93.55%Bearish. Lower is better. Substantial decline
❌Short Percent2.54%3.55%▲ 39.76%Bearish. Lower is better. Significant increase; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
❌Enterprise Value/Revenue14.677615.2739▲ 4.06%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Price Book MRQ25.484626.4925▲ 3.95%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
✅Wall Street Target Price251.2632256.95▲ 2.26%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅EPS Estimate Current Year-2.4654-2.4303▲ 1.42%Bullish. Higher is better. Slight increase; improved outlook for current year earnings
Expected earnings per share this year
✅EPS Estimate Next Year-2.0504-1.9597▲ 4.42%Bullish. Higher is better. Slight raised expectations for further out
Expected earnings per share next year
✅Enterprise Value$31.07B$32.33B▲ 4.06%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Sun 21 Dec 2025 to Tue 06 Jan 2026: Score 6

MetricPreviousNewChangeInterpretation
✅Short Percent3.04%2.54%▼ -16.45%Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
✅Short Ratio2.372.17▼ -8.44%Bullish. Lower is better. Slight improvement
✅Wall Street Target Price244.4211251.2632▲ 2.8%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅Price Book MRQ25.832125.4846▼ -1.35%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Enterprise Value/Revenue14.883214.6776▼ -1.38%Bullish. Lower is better. Slight improvement
Enterprise value divided by revenue
❌Price Sales TTM15.281815.6415▲ 2.35%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Enterprise Value$31.5B$31.07B▼ -1.38%Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments
Market capitalization plus debt minus cash